- Home
- A-Z Publications
- Current Protein and Peptide Science
- Previous Issues
- Volume 10, Issue 1, 2009
Current Protein and Peptide Science - Volume 10, Issue 1, 2009
Volume 10, Issue 1, 2009
-
-
Editorial [Hot Topic: Novel Peptides and Proteins in Diabetes Mellitus (Guest Editors: Po Sing Leung and Marc de Gasparo)]
Authors: Po S. Leung and Marc de GasparoDiabetes mellitus remains a hot research topic. More than 10,000 articles related to it have been published in the last twelve months (PubMed). In the U.S., 1.5 million new cases were diagnosed in 2005 and 6.2% of Americans are diabetic. According to the World Health Organization, approximately 197 million people worldwide have impaired glucose tolerance, most commonly attributed to obesity and metabolic syndr Read More
-
-
-
Ghrelin and Metabolic Disorders
By Olavi UkkolaGhrelin is a gut-brain peptide that has somatotropic, food intake increasing and adipogenic effects. Ghrelin is involved in modulating insulin and glucose metabolism in rodents according to recent studies. In humans acylated ghrelin reduces insulin sensitivity while unacylated ghrelin has opposite effects. In general, ghrelin seems to have diabetogenic effects. Obese, in particular abdominally obese, subjects have low ghrel Read More
-
-
-
Aminoacid Support in the Prevention of Diabetes and Diabetic Complications
More LessEmerging evidence suggests that amino acids may be potentially important in the prevention of diabetes and diabetes-associated complications. The pathways involved in the pathogenesis of diabetic complications include increased polyol pathway flux, increased advanced glycation end products formation, activation of protein kinase C and oxidative and carbonyl stress. This review will discuss the modulatory effects of a Read More
-
-
-
Connexins, Diabetes and the Metabolic Syndrome
Authors: Romain Hamelin, Florent Allagnat, Jacques - Antoine Haefliger and Paolo MedaDiabetes and the related metabolic syndrome are multi system disorders that result from improper interactions between various cell types. Even though the underlying mechanism remains to be fully understood, it is most likely that both the long and the short distance range cell interactions, which normally ensure the physiologic functioning of the pancreas, and its relationships with the insulin-targeted organs, are altered. Thi Read More
-
-
-
The Roles of the PDZ-containing Proteins Bridge-1 and PDZD2 in the Regulation of Insulin Production and Pancreatic Beta-Cell Mass
Authors: Melissa K. Thomas, Siu W. Tsang, Man-Lung Yeung, Po Sing Leung and Kwok-Ming YaoPDZ domains are versatile protein interaction modules with the ability to dimerize and to recognize internal and carboxy-terminal peptide motifs. Their function in mediating the formation of multi-molecular signaling complexes is best understood at neuronal and epithelial membranes. In a screen for interactors that regulate transcription factor function in pancreatic beta cells, we isolated two PDZ-containing proteins Bridge Read More
-
-
-
The Role of Islet Neogeneis-Associated Protein (INGAP) in Pancreatic Islet Neogenesis
Authors: Gary L. Pittenger, David Taylor-Fishwick and Aaron I. VinikEfforts to cure diabetes are now focused on restoring a physiologically-regulated population of insulinproducing cells to the patient. A number of animal models of β cell regeneration have been employed to study the mechanisms of the process. Islet neogenesis, the regeneration of pancreatic islets from pancreatic stem cells, is arguably the least fraught with barriers to widespread use as a therapy for diabetes. The Read More
-
-
-
Incretin-Based Therapy of Type 2 Diabetes Mellitus
Authors: Filip K. Knop, Tina Vilsboll and Jens J. HolstThis review article focuses on the therapeutic potential of the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), in treating type 2 diabetes mellitus (T2DM). T2DM is characterized by insulin resistance, impaired glucose-induced insulin secretion and inappropriately regulated glucagon secretion which in combination eventually result in hyperglycemia and in the lo Read More
-
-
-
The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes
More LessType 2 diabetes is closely related to abdominal obesity and is generally associated with other cardiometabolic risk factors, resulting in a high incidence of cardiovascular complications. Several animal and human observations suggest that the endocannabinoid (EC) system is overactivated in presence of abdominal obesity and/or diabetes, and contributes to disturbances of energy balance and metabolism. Not only it regula Read More
-
-
-
Angiotensin II in Type 2 Diabetes Mellitus
Authors: Kwan Y. Chu and Po Sing LeungAngiotensin II (Ang II) is well-known as a systemic vasoconstrictor but recently a novel role for the peptide in endocrine function has been suggested and it has been linked to the pathophysiology of type 2 diabetes mellitus. According to several large-scale clinical studies, blocking Ang II prevented the onset of type 2 diabetes in potential patients. Type 2 diabetes is a complicated disease that is primarily characterized by i Read More
-
-
-
Heat Shock Proteins in Diabetes and Wound Healing
Authors: Mustafa Atalay, Niku Oksala, Jani Lappalainen, David E. Laaksonen, Chandan K. Sen and Sashwati RoyThe heat shock proteins (HSPs), originally identified as heat-inducible gene products, are a highly conserved family of proteins that respond to a wide variety of stress. Although HSPs are among the most abundant intracellular proteins, they are expressed at low levels under normal physiological conditions, and show marked induction in response to various stressors. HSPs function primarily as molecular chaperones, Read More
-
-
-
Role of Resistin in Insulin Sensitivity in Rodents and Humans
Authors: K. M. Barnes and J. L. MinerResistin is a potential link between obesity and insulin resistance or type 2 diabetes. In rodents, resistin is primarily expressed in and secreted from mature adipocytes, with some expression in pancreatic islets and portions of the pituitary and hypothalamus. Its secretion can be up-regulated by several factors, including insulin and glucose. The exposure of rodents, or their cells, to resistin results in decreased response to insulin. Read More
-
Volumes & issues
-
Volume 26 (2025)
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cpps
Journal
10
5
false
en
